Pulmonx Corp (NAS:LUNG)
$ 7.9 -0.17 (-2.11%) Market Cap: 306.64 Mil Enterprise Value: 237.69 Mil PE Ratio: 0 PB Ratio: 2.77 GF Score: 61/100

Pulmonx Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 08:15PM GMT
Release Date Price: $38.24 (-1.52%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Good afternoon, and thank you for joining us for the third day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley. It's my pleasure to have Pulmonx with us today, Glen French, President and CEO; and Derrick Sung, CFO.

And before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

And with that, Glen, Derrick, thank you both for joining us today.

Glendon E. French
Pulmonx Corporation - CEO, President & Director

Thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot